The estimated Net Worth of Howard V Oconnell is at least $7.27 Million dollars as of 19 February 2015. Howard Oconnell owns over 5,000 units of Bio-Techne Corp stock worth over $5,511,750 and over the last 21 years Howard sold TECH stock worth over $1,762,330.
Howard has made over 5 trades of the Bio-Techne Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Howard exercised 5,000 units of TECH stock worth $280,850 on 19 February 2015.
The largest trade Howard's ever made was selling 15,000 units of Bio-Techne Corp stock on 4 May 2011 worth over $1,187,850. On average, Howard trades about 1,072 units every 42 days since 2003. As of 19 February 2015 Howard still owns at least 75,000 units of Bio-Techne Corp stock.
You can see the complete history of Howard Oconnell stock trades at the bottom of the page.
Howard's mailing address filed with the SEC is 7705 E. DOUBLETREE RANCH RD #20, , SCOTTSDALE, AZ, 85258.
Over the last 21 years, insiders at Bio-Techne Corp have traded over $37,160,097 worth of Bio-Techne Corp stock and bought 4,361 units worth $454,370 . The most active insiders traders include Charles R. Kummeth, Rupert Vessey, and John L Higgins. On average, Bio-Techne Corp executives and independent directors trade stock every 23 days with the average trade being worth of $964,850. The most recent stock trade was executed by Kim Kelderman on 29 August 2024, trading 1,492 units of TECH stock currently worth $99,919.
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
Bio-Techne Corp executives and other stock owners filed with the SEC include: